US company Nashai Biotech has developed a new process that
preserves and protects theaflavins, compounds found in tea, when
they are formulated into powders or liquids
Cambrex has initiated a project aimed at constructing a new
facility to accommodate four cGMP-compliant suites dedicated to
cell therapy manufacturing. The company said the expansion would
increase its manufacturing capacity by 100...
Three major players will try to recover costs from Pan
Pharmaceuticals after Australia's largest ever medical products
recall, reports IndustrySearch.com.
Ireland's Elan Corp has inked a deal with Ingenium Pharmaceuticals
of Germany that will see the companies apply Ingenium's functional
genomics technologies to the discovery and development of novel
therapeutics for pain...
Franco-German drugmaker Aventis and Germany's Bayer have agreed not
to pursue their plans to create a joint venture in the field of
biological products.